Pimavanserin in Alzheimer's Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms.
Alzforum,
. Pimavanserin in Alzheimer's Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms.
. Pimavanserin in Alzheimer's Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms.
Shares of ACADIA Pharmaceuticals (ACAD) have shed roughly a third of their value over the past three years.
SAN DIEGO--(Business Wire)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) announced today publication of additional data from a…
SAN DIEGO--( BUSINESS WIRE )--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) announced today publication of additional data from a…